Skip to main content

Alexion.US

This site is intended for US audiences. If you are in another region, please visit our global site to learn more or be directed to your local country page.

Generalized myasthenia gravis (gMG)

What is gMG?

Generalized myasthenia gravis (gMG) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. gMG can occur at any age but it most commonly begins for women before the age of 40 and for men after the age of 60.1,2 It typically begins with weakness in the muscles that control the movements of the eyes and eyelids, and often progresses to the more severe symptoms such as weakness of the head, neck, trunk, limb and respiratory muscles.3-5 gMG impacts the neuromuscular junction (NMJ), which is the connection point between nerve cells and the muscles they control.6

gMG Symptoms

gMG symptoms include: 4,5

Drooping of one or both eyelids

Blurred or double vision

Slurred speech

Lack of balance

Difficulty swallowing or choking

Extreme fatigue

Respiratory failure

It was a relief to have an answer. Now I knew why I was feeling what I was feeling, so we could make a plan."

Liz

Living with gMG

Liz, living with gMG

References

  1. Jung-Plath W, et al. Assessment of myasthenia gravis patients quality of life. The Journal of Neurological and Neurosurgical Nursing. 2023;12(2):74-83
  2. Cavanagh N, et al. Exploring the impairments and allied health professional utilization in people with myasthenia gravis: a cross-sectional study. J Clin Neurosci. 2023;114:9-16.
  3. Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419-425.
  4. Catalin J, et al. Clinical presentation of myasthenia gravis. Thymus. 2019.
  5. Farid ZR, et al. Factors affecting generalization of ocular myasthenia gravis. Sriwijaya Journal of Ophthalmology. 2020;3(2):48-54.
  6. Omar A, et al. Physiology, neuromuscular junction. StatPearls. 2023.
  7. Zhu Y, et al. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front Immunol. 2023;14(14):1223322.
  8. Huang YF, et al. Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis. Muscle Nerve. 2024.

Veeva ID: US/UNB-g/0731